Linked from

The 18 pages that link to Benign prostatic hyperplasia, each with the reason it gives.

• DihydrotestosteroneRelated: DHT signaling contributes to prostate growth and is a treatment target.

• Urinary incontinenceRelated: Outlet obstruction can cause retention and overflow-type leakage, especially in older men.

• Alpha-1 adrenergic receptorRelated: Alpha-1 receptor blockade can reduce the dynamic smooth-muscle component of its urinary obstruction.

• FinasterideRelated: Finasteride can shrink the prostate over time by lowering intraprostatic dihydrotestosterone.

• UrologyRelated: A common condition urologists assess and treat, especially in older men.

• 5α-reductaseRelated: 5α-reductase inhibitors can shrink the prostate by reducing local dihydrotestosterone.

• UrinationRelated: Prostate enlargement may weaken or interrupt the urinary stream.

• TadalafilRelated: Daily tadalafil can reduce urinary symptoms associated with this condition.

• Genitourinary systemRelated: The prostate surrounds the male urethra, linking reproductive anatomy to urination.

• Reproductive and Urinary Physiological PhenomenaRelated: It demonstrates how a reproductive organ can alter urinary function.

• SerenoaRelated: Saw palmetto products are commonly used to address symptoms associated with this condition.